PZRXQ Projected Dividend Yield
PhaseRx Inc ( OTCBB : PZRXQ )PhaseRx is a biopharmaceutical company developing a portfolio of products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy (i-ERT). Co.'s i-ERT approach is enabled by its proprietary Hybrid messenger RNA (mRNA), Technology platform, which allows synthesis of the missing enzyme inside the cell. Co.'s initial product portfolio targets the three urea cycle disorders ornithine transcarbamylase deficiency, argininosuccinate lyase deficiency, and argininosuccinate synthetase deficiency. 20 YEAR PERFORMANCE RESULTS |
PZRXQ Dividend History Detail PZRXQ Dividend News PZRXQ Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |